Achieve Life Sciences (ACHV) EBITDA Margin (2011 - 2013)
Achieve Life Sciences (ACHV) recorded quarterly EBITDA Margin of 133.89% in Q2 2013, down 1.87% on a QoQ basis from 131.43% in Q1 2013, and up 4253.0% year-over-year from 3.08% in Q2 2012.
Achieve Life Sciences (ACHV) EBITDA Margin (2011 - 2013) Analysis & Trends
Achieve Life Sciences has disclosed EBITDA Margin across 3 years of filings, most recently posting 133.89% for Q2 2013.
- Quarterly EBITDA Margin rose 4253.0% year-over-year to 133.89% in Q2 2013, while the trailing twelve-month figure through Jun 2013 was 90.44% (up 48855.0% YoY) and the FY2012 annual result came in at 104.96%, up 16126.0% from the prior year.
- EBITDA Margin retreated to 133.89% in Q2 2013, from 131.43% in the prior quarter.
- Over five years, EBITDA Margin peaked at 346.53% in Q2 2011 and troughed at 1651.92% in Q4 2011.
- A 3-year average of 308.08% and a median of 133.89% in 2013 frame the typical range for EBITDA Margin.
- Biggest YoY gain for EBITDA Margin was 160987 bps in 2012; the steepest drop was 52294 bps in 2012.
- Tracing ACHV's EBITDA Margin over 3 years: stood at 1651.92% in 2011, then soared by 97 bps to 42.05% in 2012, then slumped by 218 bps to 133.89% in 2013.
- Business Quant data shows ACHV's EBITDA Margin at 133.89% in Q2 2013, 131.43% in Q1 2013, and 42.05% in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -6.43% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Achieve Life Sciences | 93.71 Mn | 63.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | -133.89% |
| Mar 31, 2013 | -131.43% |
| Dec 31, 2012 | -42.05% |
| Sep 30, 2012 | -89.12% |
| Jun 30, 2012 | -176.42% |
| Mar 31, 2012 | -528.08% |
| Dec 31, 2011 | -1,651.92% |
| Sep 30, 2011 | -366.33% |
| Jun 30, 2011 | 346.53% |